SanBio: Announcements of individual stocks: New patent approval for cell therapy using SB623 for chronic ischemic stroke in the US

JPX · Jul 29 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.